The Audit Committee oversees the functioning of the vigil mechanism and receives a summary of the whistle-blowing incidents and actions taken by the Ethics Committee periodically. During FY 2023-24, no individual was denied access to the Audit Committee for reporting concerns, if any. Three complaints were received during the period under review, all of which were scrutinized, investigated and subsequently closed. [...] Stakeholders have numerous ways to voice their concerns and are encouraged to report the same for resolution. The policy is uploaded on the Company's website at https://www.mankindpharma.com/investors-relations/corporate-governance."
"Businesses, when engaging in influencing public and regulatory policy, should do so in a manner that is responsible and transparent. [...] The Company is committed to responsible action. As a mindful contributor to public policy and regulatory frameworks, the Company actively collaborates with governmental bodies and industry associations. It recognises its duty towards stakeholders, including customers, employees, suppliers, vendors and local communities. By aligning its operations with the interests of all stakeholders, the Company promotes sustainable development while ensuring compliance with relevant regulations.